<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33500476</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month><Day>26</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Motor cortical excitability predicts cognitive phenotypes in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>2172</StartPage><MedlinePgn>2172</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2172</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-81612-x</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are well-recognised as an extended disease spectrum. This study hypothesised that cortical hyperexcitability, an early pathophysiological abnormality in ALS, would distinguish cognitive phenotypes, as a surrogate marker of pathological disease burden. 61 patients with ALS, matched for disease duration (pure motor ALS, n&#x2009;=&#x2009;39; ALS with coexistent FTD, ALS-FTD, n&#x2009;=&#x2009;12; ALS with cognitive/behavioural abnormalities not meeting FTD criteria, ALS-Cog, n&#x2009;=&#x2009;10) and 30 age-matched healthy controls. Cognitive function on the Addenbrooke's cognitive examination (ACE) scale, behavioural function on the motor neuron disease behavior scale (MiND-B) and cortical excitability using transcranial magnetic stimulation (TMS) were documented. Cortical resting motor threshold (RMT), lower threshold indicating hyperexcitability, was lower in ALS-FTD (50.2&#x2009;&#xb1;&#x2009;6.9) compared to controls (64.3&#x2009;&#xb1;&#x2009;12.6, p&#x2009;&lt;&#x2009;0.005), while ALS-Cog (63.3&#x2009;&#xb1;&#x2009;12.7) and ALS (60.8&#x2009;&#xb1;&#x2009;13.9, not significant) were similar to controls. Short interval intracortical inhibition (SICI) was reduced across all ALS groups compared to controls, indicating hyperexcitability. On receiver operating characteristic curve analysis, RMT differentiated ALS-FTD from ALS (area under the curve AUC&#x2009;=&#x2009;0.745, p&#x2009;=&#x2009;0.011). The present study has identified a distinct pattern of cortical excitability across cognitive phenotypes in ALS. As such, assessment of cortical physiology may provide more precise clinical prognostication in ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Agarwal</LastName><ForeName>Smriti</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Brain and Mind Centre and Sydney Medical School, University of Sydney, Sydney, Australia. smriti.agarwal@cantab.net.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology Unit, A5, Box 165, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK. smriti.agarwal@cantab.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Highton-Williamson</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Brain and Mind Centre and Sydney Medical School, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caga</LastName><ForeName>Jashelle</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Brain and Mind Centre and Sydney Medical School, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howells</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Brain and Mind Centre and Sydney Medical School, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dharmadasa</LastName><ForeName>Thanuja</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Brain and Mind Centre and Sydney Medical School, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matamala</LastName><ForeName>Jos&#xe9; M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Brain and Mind Centre and Sydney Medical School, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Brain and Mind Centre and Sydney Medical School, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shibuya</LastName><ForeName>Kazumoto</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Brain and Mind Centre and Sydney Medical School, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hodges</LastName><ForeName>John R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Brain and Mind Centre and Sydney Medical School, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Rebekah M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Brain and Mind Centre and Sydney Medical School, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vucic</LastName><ForeName>Steve</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Brain and Mind Centre and Sydney Medical School, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiernan</LastName><ForeName>Matthew C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Brain and Mind Centre and Sydney Medical School, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001519" MajorTopicYN="N">Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071080" MajorTopicYN="N">Cortical Excitability</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009044" MajorTopicYN="N">Motor Cortex</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050781" MajorTopicYN="N">Transcranial Magnetic Stimulation</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>27</Day><Hour>5</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33500476</ArticleId><ArticleId IdType="pmc">PMC7838179</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-81612-x</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-81612-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eisen A, et al. Cortical influences drive amyotrophic lateral sclerosis. J. Neurol. Neurosurg Psychiatr. 2017;88:917&#x2013;924. doi: 10.1136/jnnp-2017-315573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-315573</ArticleId><ArticleId IdType="pubmed">28710326</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, et al. Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights. J. Neurol. Neurosurg. Psychiatr. 2013;84:1161&#x2013;1170. doi: 10.1136/jnnp-2012-304019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-304019</ArticleId><ArticleId IdType="pmc">PMC3786661</ArticleId><ArticleId IdType="pubmed">23264687</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377:942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Nihei K, McKee AC, Kowall NW. Patterns of neuronal degeneration in the motor cortex of amyotrophic lateral sclerosis patients. Acta Neuropathol. 1993;86:55&#x2013;64. doi: 10.1007/BF00454899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00454899</ArticleId><ArticleId IdType="pubmed">8396837</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan RH, et al. TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes. Brain. 2015;138:3110&#x2013;3122. doi: 10.1093/brain/awv220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv220</ArticleId><ArticleId IdType="pubmed">26231953</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann. Neurol. 2013;74:20&#x2013;38. doi: 10.1002/ana.23937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23937</ArticleId><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan RH, et al. Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 2017;5:76. doi: 10.1186/s40478-017-0480-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-017-0480-2</ArticleId><ArticleId IdType="pmc">PMC5658959</ArticleId><ArticleId IdType="pubmed">29078806</ArticleId></ArticleIdList></Reference><Reference><Citation>Gen&#xe7; B, et al. Apical dendrite degeneration, a novel cellular pathology for Betz cells in ALS. Sci. Rep. 2017;7:41765. doi: 10.1038/srep41765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep41765</ArticleId><ArticleId IdType="pmc">PMC5292972</ArticleId><ArticleId IdType="pubmed">28165465</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara JH, et al. Evidence for an early innate immune response in the motor cortex of ALS. J. Neuroinflamm. 2017;14:129. doi: 10.1186/s12974-017-0896-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-017-0896-4</ArticleId><ArticleId IdType="pmc">PMC5485686</ArticleId><ArticleId IdType="pubmed">28651542</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, et al. Structural brain correlates of cognitive and behavioral impairment in MND. Hum. Brain Mapp. 2016;37:1614&#x2013;1626. doi: 10.1002/hbm.23124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.23124</ArticleId><ArticleId IdType="pmc">PMC6867462</ArticleId><ArticleId IdType="pubmed">26833930</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadi B, et al. Amyotrophic lateral sclerosis affects cortical and subcortical activity underlying motor inhibition and action monitoring. Hum. Brain Mapp. 2015;36:2878&#x2013;2889. doi: 10.1002/hbm.22814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.22814</ArticleId><ArticleId IdType="pmc">PMC6869134</ArticleId><ArticleId IdType="pubmed">25913637</ArticleId></ArticleIdList></Reference><Reference><Citation>Mioshi E, et al. Cortical atrophy in ALS is critically associated with neuropsychiatric and cognitive changes. Neurology. 2013;80:1117&#x2013;1123. doi: 10.1212/WNL.0b013e31828869da.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31828869da</ArticleId><ArticleId IdType="pubmed">23427327</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippini N, et al. Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis. Neurology. 2010;75:1645&#x2013;1652. doi: 10.1212/WNL.0b013e3181fb84d1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181fb84d1</ArticleId><ArticleId IdType="pmc">PMC2974368</ArticleId><ArticleId IdType="pubmed">21041787</ArticleId></ArticleIdList></Reference><Reference><Citation>Lillo P, et al. Grey and white matter changes across the amyotrophic lateral sclerosis-frontotemporal dementia continuum. PLoS ONE. 2012;7:e43993. doi: 10.1371/journal.pone.0043993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0043993</ArticleId><ArticleId IdType="pmc">PMC3430626</ArticleId><ArticleId IdType="pubmed">22952843</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Cheah BC, Kiernan MC. Defining the mechanisms that underlie cortical hyperexcitability in amyotrophic lateral sclerosis. Exp. Neurol. 2009;220:177&#x2013;182. doi: 10.1016/j.expneurol.2009.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2009.08.017</ArticleId><ArticleId IdType="pubmed">19716820</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Kiernan MC. Transcranial magnetic stimulation for the assessment of neurodegenerative disease. Neurotherapeutics. 2017;14:91&#x2013;106. doi: 10.1007/s13311-016-0487-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-016-0487-6</ArticleId><ArticleId IdType="pmc">PMC5233629</ArticleId><ArticleId IdType="pubmed">27830492</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Kiernan MC. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease. Brain. 2006;129:2436&#x2013;2446. doi: 10.1093/brain/awl172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awl172</ArticleId><ArticleId IdType="pubmed">16835248</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon P, Kiernan MC, Vucic S. Cortical hyperexcitability precedes lower motor neuron dysfunction in ALS. Clin. Neurophysiol. 2015;126:803&#x2013;809. doi: 10.1016/j.clinph.2014.04.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2014.04.023</ArticleId><ArticleId IdType="pubmed">25227219</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Kiernan MC. Cortical excitability testing distinguishes Kennedy&#x2019;s disease from amyotrophic lateral sclerosis. Clin. Neurophysiol. 2008;119:1088&#x2013;1096. doi: 10.1016/j.clinph.2008.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2008.01.011</ArticleId><ArticleId IdType="pubmed">18313980</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Nicholson GA, Kiernan MC. Cortical excitability in hereditary motor neuronopathy with pyramidal signs: comparison with ALS. J. Neurol. Neurosurg. Psychiatr. 2010;81:97&#x2013;100. doi: 10.1136/jnnp.2008.157537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2008.157537</ArticleId><ArticleId IdType="pubmed">20019225</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon P, et al. Sensitivity and specificity of threshold tracking transcranial magnetic stimulation for diagnosis of amyotrophic lateral sclerosis: a prospective study. Lancet Neurol. 2015;14:478&#x2013;484. doi: 10.1016/S1474-4422(15)00014-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(15)00014-9</ArticleId><ArticleId IdType="pubmed">25843898</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibuya K, et al. Motor cortical function determines prognosis in sporadic ALS. Neurology. 2016;87:513&#x2013;520. doi: 10.1212/WNL.0000000000002912.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002912</ArticleId><ArticleId IdType="pubmed">27402895</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell JR, et al. The frontotemporal dementia-motor neuron disease continuum. Lancet Neurol. 2016;388:919&#x2013;931. doi: 10.1016/S0140-6736(16)00737-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)00737-6</ArticleId><ArticleId IdType="pubmed">26987909</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell JR, Kiernan MC, Vucic S, Hodges JR. (2011) Motor Neuron dysfunction in frontotemporal dementia. Brain. 2011;134:2582&#x2013;2594. doi: 10.1093/brain/awr195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr195</ArticleId><ArticleId IdType="pubmed">21840887</ArticleId></ArticleIdList></Reference><Reference><Citation>Montuschi A, et al. Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J. Neurol. Neurosurg. Psychiatr. 2015;86:168&#x2013;173. doi: 10.1136/jnnp-2013-307223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-307223</ArticleId><ArticleId IdType="pubmed">24769471</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa J, Swash M, de Carvalho M. Awaji criteria for the diagnosis of amyotrophic lateral sclerosis. Arch. Neurol. 2012;69:1410&#x2013;1417. doi: 10.1001/archneurol.2012.254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2012.254</ArticleId><ArticleId IdType="pubmed">22892641</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin. Neurophysiol. 2008;119:497&#x2013;503. doi: 10.1016/j.clinph.2007.09.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2007.09.143</ArticleId><ArticleId IdType="pubmed">18164242</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, et al. Amyotrophic lateral sclerosis&#x2014;frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph. Lateral Scler. Front. Degener. 2017;18:153&#x2013;174. doi: 10.1080/21678421.2016.1267768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1267768</ArticleId><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol. Dis. 2004;15:601&#x2013;609. doi: 10.1016/j.nbd.2003.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2003.12.012</ArticleId><ArticleId IdType="pubmed">15056468</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J. Neurol. Sci. 1999;169:13&#x2013;21. doi: 10.1016/S0022-510X(99)00210-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura F, et al. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology. 2006;66:265&#x2013;267. doi: 10.1212/01.wnl.0000194316.91908.8a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000194316.91908.8a</ArticleId><ArticleId IdType="pubmed">16434671</ArticleId></ArticleIdList></Reference><Reference><Citation>Labra J, et al. Rate of disease progression: a prognostic biomarker in ALS. J. Neurol. Neurosurg. Psychiatr. 2016;87:628&#x2013;632. doi: 10.1136/jnnp-2015-310998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-310998</ArticleId><ArticleId IdType="pubmed">26152368</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh S, et al. Validation of the Addenbrook&#x2019;s cognitive examination III in frontotemporal dementia and Alzheimers disease. Dement Geriatr. Cogn. Disord. 2013;36:242&#x2013;250. doi: 10.1159/000351671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351671</ArticleId><ArticleId IdType="pubmed">23949210</ArticleId></ArticleIdList></Reference><Reference><Citation>Reitan RM, Wolfson D. The Halstead-Reitan neuropsychological test battery. Tucson: AZ Neuropsychology Press; 1985.</Citation></Reference><Reference><Citation>Mioshi E, et al. A novel tool to detect behavioural symptoms in ALS. Amyotroph. Lateral Scler. Front. Degener. 2014;15:298&#x2013;304. doi: 10.3109/21678421.2014.896927.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.896927</ArticleId><ArticleId IdType="pubmed">24863641</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher RJ, et al. Two phases of intracortical inhibition revealed by transcranial magnetic threshold tracking. Exp. Brain Res. 2002;143:240&#x2013;248. doi: 10.1007/s00221-001-0988-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00221-001-0988-2</ArticleId><ArticleId IdType="pubmed">11880900</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantello R, Gianelli M, Civardi C, Mutani R. Magnetic brain stimulation: the silent period after the motor evoked potential. Neurology. 1992;42:1951&#x2013;1959. doi: 10.1212/WNL.42.10.1951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.42.10.1951</ArticleId><ArticleId IdType="pubmed">1407578</ArticleId></ArticleIdList></Reference><Reference><Citation>Geevasinga N, et al. Riluzole exerts transient modulating effects on cortical and axonal hyperexcitability in ALS. Amyotroph. Lateral Scler. Front. Degener. 2016;17:580&#x2013;588. doi: 10.1080/21678421.2016.1188961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1188961</ArticleId><ArticleId IdType="pubmed">27249331</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, et al. Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD) Acta Neuropathol. 2014;127:423&#x2013;439. doi: 10.1007/s00401-013-1238-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1238-y</ArticleId><ArticleId IdType="pmc">PMC3971993</ArticleId><ArticleId IdType="pubmed">24407427</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan RH, et al. Classification of FTLD-TDP cases into pathological subtypes using antibodies against phosphorylated and non-phosphorylated TDP43. Acta Neuropathol. Commun. 2013;1:33. doi: 10.1186/2051-5960-1-33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2051-5960-1-33</ArticleId><ArticleId IdType="pmc">PMC4046675</ArticleId><ArticleId IdType="pubmed">24252630</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A, Kim S, Pant B. Amyotrophic lateral sclerosis (ALS): a phylogenetic disease of the corticomotoneuron? Muscle Nerve. 1992;15:219&#x2013;224. doi: 10.1002/mus.880150215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880150215</ArticleId><ArticleId IdType="pubmed">1549143</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills KR, Nithi KA. Corticomotor threshold is reduced in early sporadic amyotrophic lateral sclerosis. Muscle Nerve. 1997;20:1137&#x2013;1141. doi: 10.1002/(SICI)1097-4598(199709)20:9&lt;1137::AID-MUS7&gt;3.0.CO;2-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4598(199709)20:9&lt;1137::AID-MUS7&gt;3.0.CO;2-9</ArticleId><ArticleId IdType="pubmed">9270669</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills KR. The natural history of central motor abnormalities in amyotrophic lateral sclerosis. Brain. 2003;126:2558&#x2013;2566. doi: 10.1093/brain/awg260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awg260</ArticleId><ArticleId IdType="pubmed">12937082</ArticleId></ArticleIdList></Reference><Reference><Citation>Phukan J, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J. Neurol. Neurosurg. Psychiatr. 2012;83:102&#x2013;108. doi: 10.1136/jnnp-2011-300188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2011-300188</ArticleId><ArticleId IdType="pubmed">21836033</ArticleId></ArticleIdList></Reference><Reference><Citation>Mioshi E, et al. Neuropsychiatric changes precede classic motor symptoms in ALS and do not affect survival. Neurology. 2014;82:149&#x2013;155. doi: 10.1212/WNL.0000000000000023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000023</ArticleId><ArticleId IdType="pubmed">24336140</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng H-J, et al. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol. 2018;17:423&#x2013;433. doi: 10.1016/S1474-4422(18)30089-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30089-9</ArticleId><ArticleId IdType="pubmed">29598923</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed RM, et al. Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism. Lancet Neurol. 2016;15:332&#x2013;342. doi: 10.1016/S1474-4422(15)00380-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(15)00380-4</ArticleId><ArticleId IdType="pubmed">26822748</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal S, et al. Primary lateral sclerosis and the amyotrophic lateral sclerosis&#x2013;frontotemporal dementia spectrum. J. Neurol. 2018;265:1819&#x2013;1828. doi: 10.1007/s00415-018-8917-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-8917-5</ArticleId><ArticleId IdType="pubmed">29868980</ArticleId></ArticleIdList></Reference><Reference><Citation>Benussi A, et al. Classification accuracy of transcranial magnetic stimulation for the diagnosis of neurodegenerative dementias. Ann Neurol. 2020;87:394&#x2013;404. doi: 10.1002/ana.25677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25677</ArticleId><ArticleId IdType="pubmed">31925823</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer I. Neurons and their dendrites in frontotemporal dementia. Dement Geriatr. Cogn. Disord. 1999;10:55&#x2013;60. doi: 10.1159/000051214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000051214</ArticleId><ArticleId IdType="pubmed">10436342</ArticleId></ArticleIdList></Reference><Reference><Citation>De Icaza Valenzuela MM, Bak TH, Pal S, Abrahams S. The Edinburgh cognitive and behavioral ALS screen: relationship to age, education, IQ and the Addenbrooke&#x2019;s cognitive examination-III. Amyotroph. Lateral Scler. Front. Degener. 2018;19:585&#x2013;590. doi: 10.1080/21678421.2018.1491601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1491601</ArticleId><ArticleId IdType="pubmed">30369272</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed RM, et al. Phenotypic variability in ALS-FTD and effect on survival. Neurology. 2020;94:e2005&#x2013;2013. doi: 10.1212/WNL.0000000000009398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009398</ArticleId><ArticleId IdType="pubmed">32277059</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh W, et al. Assessment of the upper motor neuron in amyotrophic lateral sclerosis. Clin. Neurophysiol. 2016;127:2643&#x2013;2660. doi: 10.1016/j.clinph.2016.04.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2016.04.025</ArticleId><ArticleId IdType="pubmed">27291884</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal S, et al. Interrogating cortical function with transcranial magnetic stimulation: insights from neurodegenerative disease and stroke. J. Neurol. Neurosurg. Psychiatr. 2019;90:47&#x2013;57. doi: 10.1136/jnnp-2017-317371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317371</ArticleId><ArticleId IdType="pubmed">29866706</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner JM, et al. A proposal for new diagnostic criteria for ALS. Clin. Neurophysiol. 2020;131:1975&#x2013;1978. doi: 10.1016/j.clinph.2020.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2020.04.005</ArticleId><ArticleId IdType="pubmed">32387049</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>